NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) invites submission of investigator-initiated Program Project (P01) applications. The proposed programs may address scientific areas relevant to the NIAID mission including the biology, pathogenesis, and host response to microbes, including HIV; the mechanisms of healthy immune system development and function across the lifespan; and immune dysfunction resulting in autoimmunity, immunodeficiency, allergy, asthma, and transplant rejection; and translational research to develop vaccines, therapeutics, and diagnostics to prevent and treat infectious and immune-mediated diseases. Each P01 application submitted to this FOA must include at least two related, synergistic research projects that share a common central theme, focus, and/or overall objective; and an administrative core. A P01 may include scientific cores, if needed for proposed research. 


  • Application Deadlines: January 24, 2020; June 11, 2020; January 11, 2021; June 11, 2021; January 11, 2022; June 10, 2022.
  • AIDS Deadlines: January 9, 2020; May 7, 2020; September 7, 2020; May 7, 2021; September 7, 2021; May 7, 2022; September 7, 2022.

PAR-20-072 Expiration Date: September 8, 2022

Agency Website

Eligibility Requirements

Note that the multiple PDs/PIs option may only be used for the overall Program Leader. NIAID does not support multiple Project/Core Leaders for individual Projects and Cores within a multi-project application.  

Funding Type





Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

January 11, 2022